Who Just RaisedAptevo Therapeutics Inc.
Seattle, WA ยท Pharmaceuticals
Aptevo Therapeutics Inc. is a pharmaceuticals company based in Seattle, Washington. In a Form D filed with the SEC on August 26, 2026, it reported raising $3,472,683 from 3 investors as part of an offering of up to $3,472,683. The first sale in the offering took place on August 12, 2026.
- Website
- aptevotherapeutics.com
- Amount raised
- $3,472,683
- Offering size
- $3,472,683
- Investors so far
- 3
- First sale
- August 12, 2026
- Securities offered
- Equity, Options or warrants
- Exemption claimed
- Rule 506(c)
- Industry
- Pharmaceuticals
- Headquarters
- Seattle, Washington
- Incorporated
- Delaware
- Entity type
- Corporation
- Revenue range
- No Revenues
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $3,472,683 | $3,472,683 | 3 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Other health care raises in Washington
| Company | Location | Sector | Raised | Target | Filed |
|---|---|---|---|---|---|
| Q-Immune, Inc. | Seattle, WA | Health Care | $25K | $1M | |
| Seattle Neurosound Solutions, Inc. | Seattle, WA | Health Care | $100K | $5M | |
| Hexamer Therapeutics, Inc | Pullman, WA | Health Care | $500K | $2.5M | |
| DexCare, Inc. | Seattle, WA | Health Care | $12.9M | $22.7M | |
| MalarVx, Inc. | Seattle, WA | Health Care | $125K | $2.5M | |
| Strella Biotechnology, Inc. | Seattle, WA | Health Care | $1.8M | $3.3M |